ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
äŒæ¥ã³ãŒãRSLS
äŒç€ŸåReShape Lifesciences Inc
äžå Žæ¥Oct 06, 2016
æé«çµå¶è²¬ä»»è
ãCEOãMr. Paul F. Hickey
åŸæ¥å¡æ°17
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Oct 06
æ¬ç€Ÿæåšå°1001 Calle Amanecer
éœåžSAN CLEMENTE
蚌åžååŒæNASDAQ Capital Market Consolidated
åœUnited States of America
éµäŸ¿çªå·92673
é»è©±çªå·19494296680
ãŠã§ããµã€ãhttps://www.reshapelifesciences.com/obalon/
äŒæ¥ã³ãŒãRSLS
äžå Žæ¥Oct 06, 2016
æé«çµå¶è²¬ä»»è
ãCEOãMr. Paul F. Hickey
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã